Dublin, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/8nz9fd/infectious) has announced the addition of the "Infectious Disease Diagnostics Market by Product, Application, Technology, End User - Global Forecast to 2019" report to their offering.
The infectious disease diagnostics market is expected to grow at CAGR of 7.9% to reach $18,156.2 million by 2019 from $12,422.8 million in 2014. Increase in governmental funding for diagnoses of infectious diseases, growing prevalence rate of infectious diseases, and the development of highly advanced rapid diagnostic tests for better management of infectious diseases are major factors driving the growth of global market.
The market is segmented on the basis of products (instruments, consumables, and software & services), applications (Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) infection, Human papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA) and others (Influenza, Ebola, Typhoid, Malaria, and Dengue included), technology (traditional methods (immunodiagnostics, microscopy, and biochemical characterization), and molecular diagnostics (Polymerase Chain Reaction (PCR), INAAT (Isothermal Nucleic Acid Amplification Test)), Hybridization, DNA Sequencing & NGS, microarray, and others (flow cytometry, mass spectroscopy, electrophoresis), end users (hospital laboratories, reference labs, physician office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care, self-testing)), and regions (North America, Europe, Asia-Pacific, and RoW).
On the basis of technology, the segment is divided into traditional and molecular diagnostics. Traditional diagnostics is further categorized into immunodiagnostics, microscopy, and biochemical characterization. Molecular diagnostics is divided into PCR, INAAT, Hybridization, DNA Sequencing & NGS, microarrays, and others (flow cytometry, mass spectroscopy, electrophoresis). PCR and INAAT are expected to be the largest market segments in the forecast period. Microarray, INAAT, and NGS are expected to be the fastest-growing markets. The need for faster detection of diseases and the demand for advanced technologies with better specificity and sensitivity are the major drivers of this segment.
On the basis of application, MRSA, Human papillomavirus (HPV), and AIDS are expected to be the fastest-growing segments in the forecast period. This growth is attributed to the growing prevalence of these diseases in recent years.
Geographically, the infectious disease diagnostics market is dominated by North America, followed by Europe. However, the Asia-Pacific region is expected to grow at the highest CAGR of 9.9% during the forecast period. This growth is attributed to the growing prevalence of infectious disease (tuberculosis, hepatitis and HIV) in countries such as China, India, Japan and Australia. Besides these, various awareness programs regarding prevention of infectious disease are conducted in countries such as Singapore, Australia and Malaysia.
Major players operating in the global infectious disease diagnostics market are Roche Diagnostics (Switzerland), bioMerieux (France), Bio-Rad Laboratories (U.S.), Becton and Dickinson & Co. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Infectious Disease Diagnostics Market, By Product
8 Infectious Disease Diagnostics Market, By Application
9 Infectious Disease Diagnostics Market, By Technique
10 Infectious Disease Diagnostics Market, By End User
11 Geographic Analysis
12 Competitive Landscape
13 Company Profile
14 Appendix
Companies Mentioned:
- Abbott Laboratories
- Alere, Inc.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories
- Biom�rieux
- Danaher Corporation
- Johnson and Johnson
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/8nz9fd/infectious